JP2002522791A - 急性冠状症候群の認識および診断のインビトロ方法 - Google Patents

急性冠状症候群の認識および診断のインビトロ方法

Info

Publication number
JP2002522791A
JP2002522791A JP2000565402A JP2000565402A JP2002522791A JP 2002522791 A JP2002522791 A JP 2002522791A JP 2000565402 A JP2000565402 A JP 2000565402A JP 2000565402 A JP2000565402 A JP 2000565402A JP 2002522791 A JP2002522791 A JP 2002522791A
Authority
JP
Japan
Prior art keywords
choline
group
enyl
alk
cctd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000565402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002522791A5 (https=
Inventor
ウルリッヒ、フライ
オリバー、ダンネ
アドルフ、ツシュンケ
クレメンス、ミュゲ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2002522791A publication Critical patent/JP2002522791A/ja
Publication of JP2002522791A5 publication Critical patent/JP2002522791A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Nuclear Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
JP2000565402A 1998-08-12 1999-08-11 急性冠状症候群の認識および診断のインビトロ方法 Pending JP2002522791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19836617A DE19836617C2 (de) 1998-08-12 1998-08-12 In vitro Verfahren zur Erkennung und Diagnostik akuter koronarer Syndrome
DE19836617.5 1998-08-12
PCT/EP1999/005911 WO2000010014A1 (de) 1998-08-12 1999-08-11 In vitro verfahren zur erkennung und diagnostik akuter koronarer syndrome

Publications (2)

Publication Number Publication Date
JP2002522791A true JP2002522791A (ja) 2002-07-23
JP2002522791A5 JP2002522791A5 (https=) 2009-07-09

Family

ID=7877351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000565402A Pending JP2002522791A (ja) 1998-08-12 1999-08-11 急性冠状症候群の認識および診断のインビトロ方法

Country Status (16)

Country Link
US (1) US6830932B1 (https=)
EP (1) EP1104547B1 (https=)
JP (1) JP2002522791A (https=)
AT (1) ATE242488T1 (https=)
AU (1) AU761226B2 (https=)
CA (1) CA2339023C (https=)
CZ (1) CZ299988B6 (https=)
DE (2) DE19836617C2 (https=)
DK (1) DK1104547T3 (https=)
ES (1) ES2201764T3 (https=)
HU (1) HUP0102984A3 (https=)
IL (2) IL141152A0 (https=)
NZ (1) NZ509406A (https=)
PT (1) PT1104547E (https=)
WO (1) WO2000010014A1 (https=)
ZA (1) ZA200101972B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012024014A (ja) * 2010-07-23 2012-02-09 Asahi Kasei Pharma Kk 全血コリンの測定方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103356996A (zh) * 2000-05-19 2013-10-23 埃米林药品公司 Glp-1用于制备治疗急性冠脉综合征的药物的用途
US7262017B2 (en) 2001-09-14 2007-08-28 Torrey Pines Institute For Molecular Studies Diagnostic markers for ischemia
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US20070193886A1 (en) * 2006-02-02 2007-08-23 Ian Acworth Detection methods and devices
US20070281321A1 (en) * 2006-05-31 2007-12-06 Esa Biosciences, Inc. Biosensor for measurement of species in a body fluid
CA2680748C (en) * 2007-04-13 2012-08-28 Phenomenome Discoveries Inc. Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
US7811749B2 (en) * 2008-04-21 2010-10-12 Abbott Laboratories Measuring free choline to determine suitability of erythrocytes for transfusion
JP5662060B2 (ja) * 2010-06-04 2015-01-28 学校法人帝京大学 検出方法
CN102998274A (zh) * 2012-11-30 2013-03-27 华南理工大学 一种快速测定制浆黑液中总硫含量的方法
CN111505131B (zh) * 2020-01-02 2023-03-31 东莞东华医院有限公司 基于血清代谢组学改变建立的预测冠心病斑块不稳定性临床模型

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1598739C3 (de) 1965-01-26 1973-10-11 Merck Patent Gmbh, 6100 Darmstadt Mittel zur Bestimmung der Chohnesteraseaktivitat im Serum
WO1991002532A2 (en) * 1989-08-14 1991-03-07 Queen's University At Kingston Method for stimulating fibrinolytic effect
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6008059762, 真田竹生 他, "「虚血性心疾患における血清Ｐｌａｓｍａｌｏｇｅｎの動態」", 動脈硬化, 198303, Ｖｏｌ．１１， Ｎｏ．３, Ｐ．５３５−５３９ *
JPN6008059763, 真田竹生 他, "「虚血性心疾患における血清Ｐｌａｓｍａｌｏｇｅｎの動態」", 東京慈恵会医科大学雑誌, 19850115, Ｖｏｌ．１００， Ｎｏ．１, Ｐ．１５１−１５７ *
JPN7008008440, ＡＫＩＴＡ Ｈ． ｅｔ ｓｌ．, ""Ｅｌｅｃｔｒｏｐｈｙｓｉｏｌｏｇｉｃ ｅｆｆｅｃｔｓ ｏｆ ｉｎｔｒａｃｅｌｌｕｌａｒ ｌｙｓｏｐｈｏｓｐｈｏｇｌｙｃｅｒｉｄｅｓ ａｎｄ ｔｈｅｉｒ ａｃｃｕｍｕｌａｔｉｏｎ ｉｎ ｃａｒｄｉａｃ", Ｊ Ｃｌｉｎ Ｉｎｖｅｓｔ．, 1986, Ｖｏｌ．７８、ＮＯ．１, Ｐ．２７１−８０ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012024014A (ja) * 2010-07-23 2012-02-09 Asahi Kasei Pharma Kk 全血コリンの測定方法

Also Published As

Publication number Publication date
EP1104547A1 (de) 2001-06-06
NZ509406A (en) 2003-05-30
DK1104547T3 (da) 2003-09-29
WO2000010014A1 (de) 2000-02-24
CZ299988B6 (cs) 2009-01-14
HUP0102984A2 (hu) 2001-11-28
ATE242488T1 (de) 2003-06-15
EP1104547B1 (de) 2003-06-04
IL141152A (en) 2006-08-01
PT1104547E (pt) 2003-10-31
ES2201764T3 (es) 2004-03-16
CZ2001281A3 (cs) 2001-07-11
DE19836617C2 (de) 2001-02-08
CA2339023A1 (en) 2000-02-24
ZA200101972B (en) 2003-07-02
IL141152A0 (en) 2002-02-10
AU5621999A (en) 2000-03-06
CA2339023C (en) 2009-11-17
AU761226B2 (en) 2003-05-29
DE59905860D1 (de) 2003-07-10
DE19836617A1 (de) 2000-03-16
HUP0102984A3 (en) 2005-06-28
US6830932B1 (en) 2004-12-14

Similar Documents

Publication Publication Date Title
US20240230655A1 (en) Detection of cancer biomarkers using nanoparticles
CN102105794B (zh) 移植物衰竭和死亡的标志物
ES2358846T3 (es) Medios y método para predecir diabetes tipo ii.
US20130040851A1 (en) Evaluation Method for Arteriosclerosis
EP2330423A1 (en) Means and method for diagnosing diabetes
US11598781B2 (en) Method for predicting the risk of incidence of chronic kidney disease
AU2012288742A1 (en) Means and methods for diagnosing and monitoring heart failure in a subject
WO2008061149A2 (en) Methods and compositions for diagnosis and prognosis of renal artery stenosis
Nakamura et al. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids
JP2002522791A (ja) 急性冠状症候群の認識および診断のインビトロ方法
WO2024007778A1 (zh) 一种血浆分子标志物犬尿氨酸在早期心力衰竭检测中的应用
JP4751555B2 (ja) 脳卒中のための診断アッセイ
CA2845117A1 (en) Means and methods for assessing kidney toxicity
JP2023527087A (ja) 敗血症状態の予測
PL238142B1 (pl) Sposób diagnozowania boreliozowego zapalenia stawów, sposób różnicowego diagnozowania boreliozowego zapalenia stawów oraz zastosowania lizofosfatydyloetanoloaminy jako biomarkera
WO2015058158A1 (en) METHOD FOR DETECTION OF LIPOPROTEIN-SPECIFIC Lp-PLA2 ASSOCIATION
EP4086633B1 (en) Prognostic method
HK40104057A (en) Detection of cancer biomarkers using nanoparticles
RU2541164C2 (ru) Способ одновременного детектирования нескольких маркеров врожденных заболеваний в сухих пятнах крови
CN117007819A (zh) 用于辅助诊断阿尔茨海默病的试剂盒
AU2012310100A1 (en) Means and methods for assessing kidney toxicity
HK1156104B (en) A marker for graft failure and mortality

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051228

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081121

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090223

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090521

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20090521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100528

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101026